Preview

Russian Ophthalmological Journal

Advanced search

Surgical treatment of patients with myopathic ptosis

https://doi.org/10.21516/2072-0076-2018-11-1-74-79

Abstract

Myopathic ptosis can occur in mitochondrial myopathies, oculopharyngeal muscular dystrophy or myotonic dystrophy and have common clinical characteristics. The management of myopathic ptosis is challenging due to a high risk of postoperative lagophthalmos. In this study, we report the results of surgical treatment in patients with myopathic ptosis. Purpose: to evaluate the results of treatment of patients with myopathic ptosis of the upper eyelids, operated in various ways, and propose an algorithm for choosing the method of treatment. Materials and methods. A retrospective study of 11 patients (10 females and 1 male) with myopathic ptosis was conducted. Surgical treatment included frontalis suspension using mersilene mesh with levator function ≤ 4 mm, (6 patients), resection of the levator and muscle of Muller with levator function ≥5 mm (5 patients). If excess skin of the upper eyelids was available, resection of the skin and orbicularis was additionally performed in both surgery techniques. Results. In all cases, positive values of the postoperative Marginal Reflex Distance (MRD1 = 0.5-2 mm) were obtained. Postoperative lagophthalmos was observed in two patients who underwent a recession of suspensions in an early postoperative period. In one case, the mersilene mesh was exposed on both eyes 12 months after surgery. Conclusion. The positive effect of the surgical treatment of myopathic ptosis is determined by eyelid opening to reach the values of MRD1 of at least 0 mm and a complete absence of lagophthalmos. The choice of the method of treatment is based on the correlation of levator function and the mobility of the eyebrows. In excess skin, both surgical methods are supplemented with skin and orbicularis resection. The appearance of any lagophthalmos in the postoperative period is an indication for an early corrective operation. For citation: Zakharova M.A., Kataev M.G. Surgical treatment of patients with myopathic ptosis. Russian ophthalmological journal. 2018; 11 (1): 74-9. doi: 10.21516/2072-0076-2018-11-1-74-79 (In Russian).

About the Authors

M. A. Zakharova
Svyatoslav Fyodorov Eye Microsurgery
Russian Federation


M. G. Kataev
Svyatoslav Fyodorov Eye Microsurgery
Russian Federation


References

1. Burian H.M., Burns C.A. Ocular changes in myotonic dystrophy. Am. J. Ophthalmol. 1967; 63(1): 22-34.

2. Nonaka I. Mitochondrial diseases. Curr Opin Neurol Neurosurg. 1992; 5(5): 622-32.

3. Kao K.P. Mitochondrial disease with chronic progressive external ophthalmoplegia: clinical analysis of 19 cases. Chin. Med. J. 1994; 53(2): 95-100.

4. Jordan D.R., Addison D.J. Surgical results and pathological findings in the oculopharyngeal dystrophy syndrome. Can. J. Ophthalmol. 1993; 28(1): 15-18.

5. Kalin-Hajdu E., Attas-Fox L., Huang X., et al. Comparison of two polypropylene frontalis suspension techniques in 92 patients with oculopharyngeal muscular dystrophy. Ophthal. Plast. Reconstr. Surg. 2017; 33(1): 57-60. doi: 1097/IOP.0000000000000648

6. Lane C.C., Collin J.R. Treatment of ptosis in chronic progressive external оphthalmoplegia. British Journal of Ophthalmology. 1987; 71(4): 290-4.

7. Molgat Y.M., Rodrigue D. Surgical correction of blepharoptosis in oculopharyngeal muscular dystrophy. Neuromuscul Disord. 1997; 1: 82-4.

8. Allen R.C., Zimmerman M.B., Watterberg E.A., et al. Primary bilateral silicone frontalis suspension for good levator function ptosis in oculopharyngeal muscular dystrophy. Br. J. Ophthalmol. 2012; 96(6): 841-5. doi: 10.1136/bjophthalmol-2011-300667

9. Allen R.C., Hong E.S., Zimmerman M.B., et al. Factors affecting eyelid crease formation before and after silicone frontalis suspension for adult-onset myogenic ptosis. Ophthal. Plast. Reconstr. Surg. 2015; 31(3): 227-32. doi: 10.1097/IOP.0000000000000272

10. Frueh B.R., Musch D.C. Evaluation of levator muscle integrity in ptosis with levator force measurement. Ophthalmology. 1996; 103(2): 244-50.

11. Wong V.A., Beckingsale P.S., Oley C.A., Sullivan T.J. Management of myogenic ptosis. Ophthalmology. 2002; 109(5): 1023-31.

12. Burnstine M.A., Putterman A.M. Upper blepharoplasty: a novel approach to improving progressive myopathic blepharoptosis. Ophthalmology. 1999; 106(11): 2098-100. doi:10.1016/S0161-6420(99)90489-X

13. Vemuri S., Christianson M.D., Demirci H. Correcting myogenic ptosis accompanying extraocular muscle weakness: The "Bobby Pin" procedure. Orbit. 2016; 35(5): 67-270. doi: 10.1080/01676830.2016.1193528

14. Demartelaere S.L., Blaydon S.M., Shore J.W. Tarsal switch levator resection for the treatment of blepharoptosis in patients with poor eye protective mechanisms. Ophthalmology. 2006; 113(12): 2357-63. doi: 10.1016/j.ophtha.2006.06.055

15. Holck D.E.E., Dutton J.J, DeBacker C. Lower eyelid recession combined with ptosis surgery in patients with poor ocular motility. Ophthalmology. 1997; 104: 92-5.

16. Lenake M.N., McNab A.A. The posterior approach tarsal switch procedure for myopathic ptosis: a modified technique. Ophthal Plast Reconstr Surg. 2017; 33(2): 129-31. doi: 10.1097/IOP.0000000000000673

17. Shorr N., Christenbury J.D., Goldberg R.A. Management of ptosis in chronic progressive external ophthalmoplegia. Ophthal. Plast. Reconstr. Surg. 1987; 3: 141-5.


Review

For citations:


Zakharova M.A., Kataev M.G. Surgical treatment of patients with myopathic ptosis. Russian Ophthalmological Journal. 2018;11(1):74-79. (In Russ.) https://doi.org/10.21516/2072-0076-2018-11-1-74-79

Views: 1320


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-0076 (Print)
ISSN 2587-5760 (Online)